{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T11:11:48Z","timestamp":1722942708818},"reference-count":36,"publisher":"Japanese Circulation Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1253\/circj.cj-15-1126","type":"journal-article","created":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T22:06:21Z","timestamp":1463609181000},"page":"1607-1614","source":"Crossref","is-referenced-by-count":4,"title":["Higher Hemoglobin A1c After Discharge Is an Independent Predictor of Adverse Outcomes in Patients With Acute Coronary Syndrome\u3000\u2013 Findings From the PACIFIC Registry \u2013"],"prefix":"10.1253","volume":"80","author":[{"given":"Keiji","family":"Noguchi","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamoru","family":"Sakakibara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Asakawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Tokuda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiwamu","family":"Kamiya","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yoshitani","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Oba","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, School of Public Health, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Miyauchi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Nishizaki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisao","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"},{"name":"National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyoshi","family":"Yokoi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fukuoka Sanno Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayasu","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience and Therapeutics Division of Integrated Medical Science, Graduate School of Biomedical Sciences, Hiroshima University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Kitakaze","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Matsubara","sequence":"additional","affiliation":[{"name":"Toyohashi Heart Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Ikari","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokai University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Kimura","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Yokohama City University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Origasa","sequence":"additional","affiliation":[{"name":"Division of Biostatistics and Clinical Epidemiology, School of Medicine and Pharmaceutical Sciences, University of Toyama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Isshiki","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Teikyo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Morino","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Iwate Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Daida","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Tsutsui","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the PACIFIC investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, et al. Predictors of hospital mortality in the global registry of acute coronary events. <i>Arch Intern Med<\/i> 2003; 163: 2345\u20132353.","DOI":"10.1001\/archinte.163.19.2345"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina\/non-ST elevation MI: A method for prognostication and therapeutic decision making. <i>JAMA<\/i> 2000; 284: 835\u2013842.","DOI":"10.1001\/jama.284.7.835"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Fujii T, Suzuki T, Torii S, Murakami T, Nakano M, Nakazawa G, et al. Diagnostic accuracy of Global Registry of Acute Coronary Events (GRACE) risk score in ST-elevation myocardial infarction for in-hospital and 360-day mortality in Japanese patients. <i>Circ J<\/i> 2014; 78: 2950\u20132954.","DOI":"10.1253\/circj.CJ-14-0808"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Krumholz HM, Wang Y, Chen J, Drye EE, Spertus JA, Ross JS, et al. Reduction in acute myocardial infarction mortality in the United States: Risk-standardized mortality rates from 1995\u20132006. <i>JAMA<\/i> 2009; 302: 767\u2013773.","DOI":"10.1001\/jama.2009.1178"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Takii T, Yasuda S, Takahashi J, Ito K, Shiba N, Shirato K, et al. Trends in acute myocardial infarction incidence and mortality over 30 years in Japan. <i>Circ J<\/i> 2010; 74: 93\u2013100.","DOI":"10.1253\/circj.CJ-09-0619"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ishihara M, Fujino M, Ogawa H, Yasuda S, Noguchi T, Nakao K, et al. Clinical presentation, management and outcome of Japanese patients with acute myocardial infarction in the troponin era: Japanese registry of acute myocardial infarction diagnosed by universal definition (J-MINUET). <i>Circ J<\/i> 2015; 79: 1255\u20131262.","DOI":"10.1253\/circj.CJ-15-0217"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Shihara M, Tsutsui H, Tsuchihashi M, Tada H, Kono S, Takeshita A. In-hospital and one-year outcomes for patients undergoing percutaneous coronary intervention for acute myocardial infarction. <i>Am J Cardiol<\/i> 2002; 90: 932\u2013936.","DOI":"10.1016\/S0002-9149(02)02656-5"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Taneja AK, Collinson J, Flather MD, Bakhai A, de Arenaza DP, Wang D, et al. Mortality following non-ST elevation acute coronary syndrome: 4 years follow-up of the PRAIS UK Registry (Prospective Registry of Acute Ischaemic Syndromes in the UK). <i>Eur Heart J<\/i> 2004; 25: 2013\u20132018.","DOI":"10.1016\/j.ehj.2004.08.009"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kinoshita N, Imai K, Kinjo K, Naka M. Longitudinal study of acute myocardial infarction in the southeast Osaka district from 1988 to 2002. <i>Circ J<\/i> 2005; 69: 1170\u20131175.","DOI":"10.1253\/circj.69.1170"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tang EW, Wong CK, Herbison P. Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome. <i>Am Heart J<\/i> 2007; 153: 29\u201335.","DOI":"10.1016\/j.ahj.2006.10.004"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Roe MT, Chen AY, Thomas L, Wang TY, Alexander KP, Hammill BG, et al. Predicting long-term mortality in older patients after non-ST-segment elevation myocardial infarction: The CRUSADE long-term mortality model and risk score. <i>Am Heart J<\/i> 2011; 162: 875\u2013883.e1, doi:10.1016\/j.ahj.2011.08.010.","DOI":"10.1016\/j.ahj.2011.08.010"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Coles AH, Fisher KA, Darling C, McManus D, Maitas O, Yarzebski J, et al. Recent trends in post-discharge mortality among patients with an initial acute myocardial infarction. <i>Am J Cardiol<\/i> 2012; 110: 1073\u20131077.","DOI":"10.1016\/j.amjcard.2012.05.046"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nakatani D, Sakata Y, Suna S, Usami M, Matsumoto S, Shimizu M, et al. Incidence, predictors, and subsequent mortality risk of recurrent myocardial infarction in patients following discharge for acute myocardial infarction. <i>Circ J<\/i> 2013; 77: 439\u2013446.","DOI":"10.1253\/circj.CJ-11-1059"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. JCS Joint Working Group. Guidelines for secondary prevention of myocardial infarction (JCS 2011): Digest version. <i>Circ J<\/i> 2013; 77: 231\u2013248.","DOI":"10.1253\/circj.CJ-66-0053"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Miyauchi K, Morino Y, Tsukahara K, Origasa H, Daida H; PACIFIC steering committee members. The PACIFIC (Prevention of AtherothrombotiC Incidents Following Ischemic Coronary attack) Registry: Rationale and design of a 2-year study in patients initially hospitalised with acute coronary syndrome in Japan. <i>Cardiovasc Drugs Ther<\/i> 2010; 24: 77\u201383.","DOI":"10.1007\/s10557-010-6223-2"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Daida H, Miyauchi K, Ogawa H, Yokoi H, Matsumoto M, Kitakaze M, et al. Management and 2-year long-term clinical outcome of acute coronary syndrome in Japan. <i>Circ J<\/i> 2013; 77: 934\u2013943.","DOI":"10.1253\/circj.CJ-13-0174"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. <i>N Engl J Med<\/i> 2008; 359: 1577\u20131589.","DOI":"10.1056\/NEJMoa0806470"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ray KK, Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D, et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: A meta-analysis of randomised controlled trials. <i>Lancet<\/i> 2009; 373: 1765\u20131772.","DOI":"10.1016\/S0140-6736(09)60697-8"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Gerstein HC, Miller ME, Ismail-Beigi F, Largay J, McDonald C, Lochnan HA, et al. Effects of intensive glycaemic control on ischaemic heart disease: Analysis of data from the randomised, controlled ACCORD trial. <i>Lancet<\/i> 2014; 384: 1936\u20131941.","DOI":"10.1016\/S0140-6736(14)60611-5"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Erdmann E, Dormandy JA, Charbonnel B, Massi-Benedetti M, Moules IK, Skene AM. The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: Results from the PROactive (PROactive 05) study. <i>J Am Coll Cardiol<\/i> 2007; 49: 1772\u20131780.","DOI":"10.1016\/j.jacc.2006.12.048"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Smith SC Jr, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, et al. AHA\/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: A guideline from the American Heart Association and American College of Cardiology Foundation. <i>Circulation<\/i> 2011; 124: 2458\u20132473.","DOI":"10.1161\/CIR.0b013e318235eb4d"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). <i>Eur Heart J<\/i> 2012; 33: 1635\u20131701.","DOI":"10.1093\/eurheartj\/ehs092"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Currie CJ, Peters JR, Tynan A, Evans M, Heine RJ, Bracco OL, et al. Survival as a function of HbA(1c) in people with type 2 diabetes: A retrospective cohort study. <i>Lancet<\/i> 2010; 375: 481\u2013489.","DOI":"10.1016\/S0140-6736(09)61969-3"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, et al. Effects of intensive glucose lowering in type 2 diabetes. <i>N Engl J Med<\/i> 2008; 358: 2545\u20132559.","DOI":"10.1056\/NEJMoa0802743"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Riddle MC, Ambrosius WT, Brillon DJ, Buse JB, Byington RP, Cohen RM, et al. Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. <i>Diabetes Care<\/i> 2010; 33: 983\u2013990.","DOI":"10.2337\/dc09-1278"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Bonds DE, Miller ME, Bergenstal RM, Buse JB, Byington RP, Cutler JA, et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: Retrospective epidemiological analysis of the ACCORD study. <i>BMJ<\/i> 2010; 340: b4909.","DOI":"10.1136\/bmj.b4909"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Goto A, Arah OA, Goto M, Terauchi Y, Noda M. Severe hypoglycaemia and cardiovascular disease: Systematic review and meta-analysis with bias analysis. <i>BMJ<\/i> 2013; 347: f4533.","DOI":"10.1136\/bmj.f4533"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Spencer FA, Gore JM, Yarzebski J, Lessard D, Jackson EA, Goldberg RJ. Trends (1986 to 1999) in the incidence and outcomes of in-hospital stroke complicating acute myocardial infarction (The Worcester Heart Attack Study). <i>Am J Cardiol<\/i> 2003; 92: 383\u2013388.","DOI":"10.1016\/S0002-9149(03)00654-4"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29. Bi Y, Gao R, Patel A, Su S, Gao W, Hu D, et al. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: Results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study. <i>Am Heart J<\/i> 2009; 157: 509\u2013516.e1, doi:10.1016\/j.ahj.2008.09.026.","DOI":"10.1016\/j.ahj.2008.09.026"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Wang R, Neuenschwander FC, Lima Filho A, Moreira CM, Santos ES, Reis HJ, et al. Use of evidence-based interventions in acute coronary syndrome: Subanalysis of the ACCEPT registry. <i>Arq Bras Cardiol<\/i> 2014; 102: 319\u2013326.","DOI":"10.5935\/abc.20140033"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Pedrazzini G, Santoro E, Latini R, Fromm L, Franzosi MG, Mocetti T, et al. Causes of death in patients with acute myocardial infarction treated with angiotensin-converting enzyme inhibitors: Findings from the Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Infarto (GISSI)-3 trial. <i>Am Heart J<\/i> 2008; 155: 388\u2013394.","DOI":"10.1016\/j.ahj.2007.10.015"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. <i>Lancet<\/i> 1995; 345: 669\u2013685.","DOI":"10.1016\/S0140-6736(95)90865-X"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the survival and ventricular enlargement trial: The SAVE Investigators. <i>N Engl J Med<\/i> 1992; 327: 669\u2013677.","DOI":"10.1056\/NEJM199209033271001"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Fox KM. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: Randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). <i>Lancet<\/i> 2003; 362: 782\u2013788.","DOI":"10.1016\/S0140-6736(03)14286-9"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. The Beta-Blocker Pooling Project Research Group. The Beta-Blocker Pooling Project (BBPP): Subgroup findings from randomized trials in post infarction patients. <i>Eur Heart J<\/i> 1988; 9: 8\u201316.","DOI":"10.1093\/oxfordjournals.eurheartj.a062395"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Oldridge NB, Guyatt GH, Fischer ME, Rimm AA. Cardiac rehabilitation after myocardial infarction: Combined experience of randomized clinical trials. <i>JAMA<\/i> 1988; 260: 945\u2013950.","DOI":"10.1001\/jama.1988.03410070073031"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/80\/7\/80_CJ-15-1126\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T20:49:45Z","timestamp":1567889385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/80\/7\/80_CJ-15-1126\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-15-1126","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"type":"print","value":"1346-9843"},{"type":"electronic","value":"1347-4820"}],"subject":[],"published":{"date-parts":[[2016]]}}}